This inventor holds 197 USPTO granted patents and 93 published patent applications, plus 10 CIPO patents and 26 EPO patents, primarily in Nucleic Acid Analysis (CPC class C12Q1-6883). Top assignees: California Institute of Technology, Leland Stanford Junior University, University of California. Active years: 1999-2026.
Inventors with similar research interests:
Location History:
- New York, NY (US) (2006)
- Pasadena, CA (US) (1999 - 2012)
- San Mateo, CA (US) (2014)
- Palo Alto, CA (US) (2016 - 2018)
- San Marino, CA (US) (2001 - 2019)
- San Francisco, CA (US) (2022 - 2023)
- Stanford, CA (US) (2007 - 2024)
Company Filing History:
122 out of 4,622 
66 out of 5,489 
12 out of 15,964 
Years Active: 1999-2026
Areas of Expertise:
Title: Stephen R Quake: Revolutionizing Biology and Medicine Through Microfluidics
Introduction:
Microfluidics is a rapidly advancing field that focuses on manipulating and analyzing small volumes of fluids at the microscale level. Among the pioneers in this field, Stephen R Quake's groundbreaking work has revolutionized the realms of biology and medicine. With a remarkable number of patents and influential contributions, Quake's innovative techniques have had a profound impact on scientific research and healthcare advancements.
Latest Patents:
Stephen R Quake, with his expertise in microfluidics, has recently obtained patents that demonstrate his dedication to solving critical challenges in biology and medicine. His patented inventions include:
1. Identifying human B cells expressing anti-allergen antibodies:
These methods aim to generate human monoclonal antibodies that specifically bind to allergens. The antibodies are derived from sequences discovered in isolated single B cells from individuals who experience allergies. By identifying and targeting these antibodies, novel strategies for allergy treatment and prevention can be developed.
2. Non-invasive diagnosis of graft rejection in organ transplant patients:
This patent introduces methods, devices, compositions, and kits for diagnosing or predicting the status and outcome of transplants in patients. By utilizing Quake's microfluidic techniques, this innovation enables non-invasive monitoring of organ transplant rejection, leading to improved patient care and timely intervention.
Career Highlights:
Stephen R Quake's illustrious career is marked by numerous achievements and contributions to the field of microfluidics. As a leading researcher, he has held positions at esteemed institutions, including the California Institute of Technology and Stanford University. Throughout his journey, Quake has been committed to pushing the boundaries of knowledge and translating his discoveries into practical applications.
Collaborations:
In his quest for innovation, Quake has collaborated with esteemed colleagues, including Hou-Pu Chou and Carl L Hansen, who have played significant roles in supporting his research endeavors. By joining forces with fellow scientists, Quake has fostered an environment of collaboration and knowledge exchange, leading to further advancements in microfluidic technologies.
Conclusion:
Stephen R Quake's pioneering work in microfluidics has transformed the landscape of biology and medicine. Through his numerous patents, he has demonstrated a deep commitment to improving healthcare outcomes and pushing the boundaries of scientific knowledge. With continued research and collaboration, Quake's innovative contributions are set to revolutionize the field further, paving the way for exciting developments in the future.